Mills Kenneth T.'s Form 4 filing
REGENXBIO Inc. (RGNX) · filed Jul 26, 2024
- Accession no.
- 0001562180-24-005855
- Filed
- Jul 26, 2024
- Trade date
- Jul 24-25, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $383.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mills Kenneth T.CIK 0001652824 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 24, 2024 | Common Stock | MOption exerciseAcquired | +12,221 | $3.76 | +$45,950.96 | 420,256 | Direct | |
| Jul 24, 2024 | Common Stock | SSaleDisposed | −12,221 | $13.78 | −$168,405.38 | 408,035 | Direct | |
| Jul 25, 2024 | Common Stock | MOption exerciseAcquired | +15,369 | $3.76 | +$57,787.44 | 423,404 | Direct | |
| Jul 25, 2024 | Common Stock | SSaleDisposed | −15,369 | $13.96 | −$214,551.24 | 408,035 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 24, 2024 | Common Stock | MOption exerciseDisposed | −12,221 | $0.00 | $0 | 66,723 | Direct | |
| Jul 25, 2024 | Common Stock | MOption exerciseDisposed | −15,369 | $0.00 | $0 | 51,354 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.